Distinguishable INNs: A Global Solution Richard Dolinar, MD Chairman, Alliance for Safe Biologic Medicines Presented at the 58 th Consultation on International.
U.S. and European Physician Perspectives on Biosimilar Naming and Substitution Michael S. Reilly, Esq. Executive Director, Alliance for Safe Biologic Medicines.
Distinguishable INNs: A Global Solution
U.S. and European Physician Perspectives on Biosimilar Naming and Substitution
